Blast Crisis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2010-03-02
Clinical Trial Update: Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate [Phase 2]
Phase 2 trial evaluating dasatinib in patients with chronic myeloid leukemia in blast crisis who were resistant or intolerant to imatinib; t…